Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward
Phillips, E.J., Bouchard, C.S. and Divito, S.J. (2022) Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward. JAMA Dermatology . Online First.
*Subscription may be required
Abstract
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is the most life-threatening disease managed by dermatologists. Although SJS/TEN only affects 1 to 5 million people per year, mortality remains stable at 15%, and to our knowledge, high-level evidence-based treatment options are lacking. The SJS/TEN meeting1,2 that was held virtually August 28 and 29, 2021, brought together multidisciplinary clinicians, scientists, and community members to share knowledge, research, stories, and support. In this Viewpoint, we provide our perspective of the successes and gaps in research and clinical care of SJS/TEN that were highlighted at this meeting and propose future opportunities for prioritization and optimization.
Item Type: | Journal Article |
---|---|
Murdoch Affiliation(s): | Institute for Immunology and Infectious Diseases |
Publisher: | JAMA Network |
Copyright: | © 2022 American Medical Association. |
URI: | http://researchrepository.murdoch.edu.au/id/eprint/64571 |
![]() |
Item Control Page |